Pfizer says Covid drug offers strong protection and should work against Omicron
Published
Data confirm Paxlovid cuts risk of hospitalisation or death by 89% for highly vulnerable patients
Full ArticlePublished
Data confirm Paxlovid cuts risk of hospitalisation or death by 89% for highly vulnerable patients
Full ArticleFinal trial results show Paxlovid cuts risk by 89% for highly vulnerable patients